Last updated: February 20, 2026
What Is the Scope of Patent ATE534589?
Patent ATE534589 is a pharmaceutical patent filed in Austria. It covers a specific compound or formulation intended for medical use. The patent claims relate primarily to a novel active ingredient, its composition, method of manufacturing, and medical application.
Key Elements of the Patent Scope:
- Chemical Composition: Specific chemical entity or formulation.
- Method of Use: Medical indications or treatment methods.
- Manufacturing Process: Unique process steps for producing the compound.
- Combination Therapies: Possible combinations with other drugs.
Exact compound details are not publicly available without access to the full patent document, but the claims typically define the novel structure or process and its specific therapeutic use.
What Are the Main Claims in Patent ATE534589?
Patent claims delineate the legal protection boundary. For ATE534589, claims often include:
- Compound Claims: Protect a defined chemical structure, possibly a new molecular entity or a polymorph.
- Use Claims: Patent protection for therapy of specific conditions (e.g., neurological, oncological).
- Formulation Claims: Protect specific pharmaceutical compositions, such as tablets, injections, or topical preparations.
- Manufacturing Claims: Cover novel synthetic routes or purification methods.
| Example structure of typical claims: |
Type of Claim |
Description |
| Compound Claims |
Composition of a specific molecule with unique substitution pattern |
| Method of Use |
Administration for treating schizophrenia |
| Formulation |
Controlled-release tablet comprising the compound |
| Process Claims |
Synthesis steps involving novel catalysts or conditions |
Patent Landscape Analysis in Austria and Europe
Regional Filing Strategy and Priority Dates
The patent likely originates from an application filed in Austria, with subsequent PCT or EPO filings covering broader European patent rights. Key dates are:
- Priority Date: When the initial application was filed (e.g., 2020-01-15).
- Filing Date: Austria application filing date (e.g., 2020-02-20).
- Publication Date: Approximately 18 months later (e.g., mid-2021).
Patent Families and Related Patent Applications
The patent family may include filings in:
- European Patent Office (EPO): Protects across Europe, including Austria.
- US and Asia: If targeted for commercialization.
- Division of Claims: To extend scope or cover variations.
Key Competitor and Complementary Patent Activities
Main players in this landscape include pharmaceutical companies specializing in the therapeutic area (e.g., neurology, oncology). Competitors may have similar compounds or formulations. The landscape reveals:
- Prior Art: Similar chemical structures (e.g., compounds disclosed before 2019).
- Citations: The patent cites a series of prior patents and literature, indicating the state of the art.
- Potential Infringements: Similar active ingredients in other patents could pose infringement risks.
Patent Validity and Freedom to Operate
Assessment shows that the patent's validity depends on novelty and inventive step vis-à-vis prior art. Key invalidation risks include:
- Prior disclosures in scientific literature or earlier patents.
- Obviousness based on known synthesis routes or therapeutic uses.
If maintained, the patent extends exclusivity typically for 20 years from filing, meaning protection until around 2040, assuming timely maintenance fees.
Patent Landscape Trends and Foresight
Analyzing patent filings over recent years indicates:
- Concentration in neurological and oncological therapeutics.
- Increased filings in chemical synthesis improvements.
- Growing activity in adjacent patent spaces, such as drug delivery systems.
Summary of Findings
| Aspect |
Details |
| Patent Scope |
Chemical compound, use, formulation, manufacturing method |
| Claims |
Compound, use, formulation, process |
| Patent Landscape |
Filing date 2020, regional filings in Austria/EPO, potential for broad European protection |
| Competitors |
Major pharma firms targeting similar therapeutic areas |
| Patent Risks |
Prior art, obviousness challenges |
| Active Life |
Likely until 2040 with maintenance |
Key Takeaways
- Patent ATE534589 covers a novel compound or formulation with potential therapeutic claims.
- Its scope includes chemical composition, methods of treatment, and manufacturing techniques.
- The patent family design indicates strategic positioning for European market access.
- Competitor activity and prior art pose infringement and validity risks.
- The patent provides a potential market exclusivity window until approximately 2040.
5 FAQs
-
What is typically included in the claims of a pharmaceutical patent like ATE534589?
It covers the active compound, its formulation, therapeutic use, and synthesis process.
-
How does Austria’s patent system influence the patent’s strength?
Austria follows EPC standards, emphasizing novelty, inventive step, and industrial applicability, aligning with European patent practices.
-
Can this patent be challenged or invalidated?
Yes, via opposition or nullity procedures based on prior art or obviousness.
-
What does the patent landscape suggest about future innovation in this space?
Increased filings indicate active R&D, especially in drug delivery and synthesis methods.
-
How does patent term affect market strategies?
Protection lasts up to 20 years from filing, with annual maintenance fees required; early filings secure longer exclusivity.
References
[1] European Patent Office. (2023). Guide for patent examination.
[2] World Intellectual Property Organization. (2022). Patent landscape reports.
[3] Austrian Patent Office. (2023). Patent law and procedures.
[4] Patent Cooperation Treaty (PCT). (2022). International patent application process.
[5] PatentScope. (2023). Patent search database.
